Luis Arturo Camacho-Saavedra

Luis Arturo Camacho-Saavedra

Auto-generated profile, based on publicly available information

Luis Arturo Camacho-Saavedra

Hospital I Essalud Florencia de Mora, La Libertad, Perú

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2015 in Medwave
Verified
Journal Article
Open access
MÁMayita Lizbeth Álvarez-Vargas
Mayita Lizbeth Álvarez-Vargas
JGJose Galvez-Olortegui
Jose Galvez-Olortegui
TGTomas Vladimir Galvez-Olortegui
Tomas Vladimir Galvez-Olortegui
JSJosé Manuel Sosa-Rosado
José Manuel Sosa-Rosado
LCLuis Arturo Camacho-Saavedra
Luis Arturo Camacho-Saavedra
The aim of this study is the methodological evaluation of Clinical Practice Guidelines (CPG) in hypertension. This is the first in a series of review articles, analysis, assessment in methodology and content of clinical practice guidelines in Cardiology. Of all clinical practice guidelines, three were selected and the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was used to assess each guide. The guidelines obtained the lowest score in the domain of applicability (mean 43.8%); while the highest score was for clarity of presentation (mean 81.5%). The lowest percentage was found in the applicability domain (European guideline) and the highest of all scores was found in two domains: scope and purpose, and clarity of presentation (Canadian guideline). Assessing the quality of the clinical practice guidelines analyzed, the Canadian is one with the best scores obtained by applying the AGREE II instrument, and it is advised to be used without modifications.

14 January 2016 in Medwave
Verified
Journal Article
Open access
JGJose Galvez-Olortegui
Jose Galvez-Olortegui
MÁMayita Lizbeth Álvarez-Vargas
Mayita Lizbeth Álvarez-Vargas
TGTomas Vladimir Galvez-Olortegui
Tomas Vladimir Galvez-Olortegui
AGArmando Godoy-Palomino
Armando Godoy-Palomino
LCLuis Camacho-Saavedra
Luis Camacho-Saavedra
The aim of this study is the methodological evaluation of Clinical Practice Guidelines (CPG) in atrial fibrillation. This is the second in a series of articles of review, analysis, assessment in methodology and content of clinical practice guidelines in Cardiology. Among all clinical practice guidelines, we selected the American, Canadian and NICE (National Institute for Health and Care Excellence) guidelines. We used the AGREE (Appraisal of Guidelines for Research & Evaluation) II instrument for the assessment. In general, the guidelines obtained the lowest score in the applicability domain (mean 36.19%); while the highest score was for clarity of presentation (mean 93.59%). The lowest percentage was found in the editorial independence domain (Canadian guideline) and the highest of all scores in the applicability domain (NICE guideline). Regarding global quality, the NICE guideline obtained the AGREE II instrument best scores, followed by the American guideline, both recommended for use without modincations.

31 July 2020 in Revista Médica Herediana
Verified
Journal Article
Open access
PDF file
MPMartín Abel Paredes-Muñoz
Martín Abel Paredes-Muñoz
HMHéctor Alberto Montoya-Rojas
Héctor Alberto Montoya-Rojas
FPFrancis Robert Pino-Zavaleta
Francis Robert Pino-Zavaleta
VPVíctor Manuel Ponce-Mendoza
Víctor Manuel Ponce-Mendoza
JRJhunior Darwin Heber Reyes-Chávez
Jhunior Darwin Heber Reyes-Chávez
LCLuis Arturo Camacho-Saavedra
Luis Arturo Camacho-Saavedra
El aneurisma del seno de Valsalva es una entidad poco frecuente, con una incidencia de 0,09 a 0,15%, en algunos casos los pacientes se presentan asintomaticos siempre que el aneurisma se encuentre integro. Si se perfora, se manifiesta como un cuadro de insuficiencia cardiaca rapidamente progresiva. Comunicamos el caso de una paciente de 27 afios sin comorbilidades, con rotura del aneurisma del seno de Valsalva y se realiza una revision bibliografica del tema.

1 October 2016 in Archivos de Cardiología de México
Verified
Journal Article
Closed access
JGJose Galvez-Olortegui
Jose Galvez-Olortegui
YCYudy Condor-Rojas
Yudy Condor-Rojas
TGTomas Vladimir Galvez-Olortegui
Tomas Vladimir Galvez-Olortegui
LCLuis Camacho-Saavedra
Luis Camacho-Saavedra
This paper analyzes the feasibility of the implementation of SPRINT trial results, the need to rethink the clinical practice guidelines(CPG) for the management of arterial hypertension and associated costs with daily practice applicability. SPRINT is a clinical trial comparing systolic blood pressure control <120mmHg and <140mmHg over cardiovascular complications, generating a great worldwide impact followed by publication of several studies that addressed relevance, usefulness, applicability and controversial aspects of SPRINT from different perspectives. Achieving blood pressure goals is one of the most discussed issue in widely used hypertension CPG around the world and in Latin American. SPRINT has generated and will generate a great impact on CPG, being necessary the reassessment of blood pressure goals and inclusion in future CPG, as has been considered in 2016 Canadian guideline and will be considered in NICE guideline update scheduled for June. The SPRINT trial raises new evidence for the management of hypertension, useful in people over 50 years, from urban populations, with defined cardiovascular risk without associated comorbidities. The applicability of SPRINT in Latin America is limited by increased costs associated with hypertensive patients' integrated health care, low care coverage, and lack of integrated care programs.

1 December 2016 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
JGJose Galvez-Olortegui
Jose Galvez-Olortegui
LCLuis Camacho-Saavedra
Luis Camacho-Saavedra
AGArmando Godoy-Palomino
Armando Godoy-Palomino
JSJose Sosa-Rosado
Jose Sosa-Rosado
TGTomas Galvez-Olortegui
Tomas Galvez-Olortegui

31 December 2024 in Revista de la Sociedad Peruana de Medicina Interna
Verified
Journal Article
Closed access
LCLuis Arturo Camacho-Saavedra
Luis Arturo Camacho-Saavedra
JCJhoan Anthony Casamayor-Quipuzcoa
Jhoan Anthony Casamayor-Quipuzcoa
Con el objetivo de identificar la frecuencia de uso racional de antibióticos en infecciones comunes, se realizó un estudio, de tipo observacional longitudinal retrospectivo en pacientes adultos de consulta externa en el hospital II-E Florencia de Mora, La Libertad Essalud, de enero a diciembre del 2022. Se incluyeron 510 pacientes adultos, con edad promedio 56,25 ± 3,77 años; 39,22% fueron varones y 60,78% mujeres. 100 pacientes con enfermedad diarreica aguda (EDA) y 410 con infecciones respiratorias altas (IRAs), de los cuales 111 con amigdalitis aguda, 95 bronquitis aguda, 104 faringitis aguda y 100 rinofaringitis. 78,82% de los pacientes fueron atendidos en medicina general. Se prescribió antibióticos en 59,61% del total de pacientes; En EDA fue en 60% de los pacientes y en IRAs en el 59,51%. Del total de IRAs, se indicó antibióticos en el 86,49% de amigdalitis, en el 68,42% de bronquitis, en el 70,19% de faringitis y en el 10% de rinofaringitis. Entre los antibióticos prescritos en EDA se indicó Trimetoprim/Sulfametoxazol en el 51,67% y Ciprofloxacino en el 35%. En IRAs se prescribió penicilinas en 41% y Azitromicina en 36,63%. Se concluye que la prescripción de antibióticos en infecciones comunes en la muestra evaluada es no racional por superar el 30% recomendado.